Calcitriol Attenuates Doxorubicin-Induced Cardiac Dysfunction and Inhibits Endothelial-to-Mesenchymal Transition in Mice

Doxorubicin (Dox) is an effective anti-neoplasm drug, but its cardiac toxicity limits its clinical use. Endothelial-to-mesenchymal transition (EndMT) has been found to be involved in the process of heart failure. It is unclear whether EndMT contributes to Dox-induced cardiomyopathy (DoIC). Calcitrio...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tzu-Hsien Tsai, Cheng-Jei Lin, Chi-Ling Hang, Wei-Yu Chen
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2019-08-01
Edice:	Cells
Témata:	endothelial-to-mesenchymal transition doxorubin cardiac fibrosis calcitriol
On-line přístup:	https://www.mdpi.com/2073-4409/8/8/865
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!